BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 30720090)

  • 1. Downregulation of protein disulfide‑isomerase A3 expression inhibits cell proliferation and induces apoptosis through STAT3 signaling in hepatocellular carcinoma.
    Kondo R; Ishino K; Wada R; Takata H; Peng WX; Kudo M; Kure S; Kaneya Y; Taniai N; Yoshida H; Naito Z
    Int J Oncol; 2019 Apr; 54(4):1409-1421. PubMed ID: 30720090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo and in vitro effects of microRNA-221 on hepatocellular carcinoma development and progression through the JAK-STAT3 signaling pathway by targeting SOCS3.
    Huang S; Zhou D; Li YX; Ming ZY; Li KZ; Wu GB; Chen C; Zhao YN
    J Cell Physiol; 2019 Apr; 234(4):3500-3514. PubMed ID: 30370582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GNAS promotes inflammation-related hepatocellular carcinoma progression by promoting STAT3 activation.
    Ding H; Zhang X; Su Y; Jia C; Dai C
    Cell Mol Biol Lett; 2020; 25():8. PubMed ID: 32123532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidatively Modified Protein-Disulfide Isomerase-Associated 3 Promotes Dyskerin Pseudouridine Synthase 1-Mediated Malignancy and Survival of Hepatocellular Carcinoma Cells.
    Ko E; Kim JS; Ju S; Seo HW; Chang Y; Kang JA; Park SG; Jung G
    Hepatology; 2018 Nov; 68(5):1851-1864. PubMed ID: 29672884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
    Zhang H; Tan YP; Zhao L; Wang L; Fu NJ; Zheng SP; Shen XF
    Cell Death Dis; 2020 Jan; 11(1):63. PubMed ID: 31980595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downregulation of PDIA3 inhibits gastric cancer cell growth through cell cycle regulation.
    Yang M; Li Q; Yang H; Li Y; Lu L; Wu X; Liu Y; Li W; Shen J; Xiao Z; Zhao Y; Du F; Chen Y; Deng S; Cho CH; Li X; Li M
    Biomed Pharmacother; 2024 Apr; 173():116336. PubMed ID: 38412717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a novel azaspirane that targets the Janus kinase-signal transducer and activator of transcription (STAT) pathway in hepatocellular carcinoma in vitro and in vivo.
    Mohan CD; Bharathkumar H; Bulusu KC; Pandey V; Rangappa S; Fuchs JE; Shanmugam MK; Dai X; Li F; Deivasigamani A; Hui KM; Kumar AP; Lobie PE; Bender A; Basappa ; Sethi G; Rangappa KS
    J Biol Chem; 2014 Dec; 289(49):34296-307. PubMed ID: 25320076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA TINCR promotes hepatocellular carcinoma proliferation and invasion via STAT3 signaling by direct interacting with T-cell protein tyrosine phosphatase (TCPTP).
    Tang C; Feng W; Bao Y; Du H
    Bioengineered; 2021 Dec; 12(1):2119-2131. PubMed ID: 34057016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascochlorin, an isoprenoid antibiotic inhibits growth and invasion of hepatocellular carcinoma by targeting STAT3 signaling cascade through the induction of PIAS3.
    Dai X; Ahn KS; Kim C; Siveen KS; Ong TH; Shanmugam MK; Li F; Shi J; Kumar AP; Wang LZ; Goh BC; Magae J; Hui KM; Sethi G
    Mol Oncol; 2015 Apr; 9(4):818-33. PubMed ID: 25624051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UBE2S promotes malignant properties via VHL/HIF-1α and VHL/JAK2/STAT3 signaling pathways and decreases sensitivity to sorafenib in hepatocellular carcinoma.
    Wu J; Xu X; Wu S; Shi W; Zhang G; Cao Y; Wang Z; Wu J; Jiang C
    Cancer Med; 2023 Sep; 12(17):18078-18097. PubMed ID: 37563971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oct4 promotes cancer cell proliferation and migration and leads to poor prognosis associated with the survivin/STAT3 pathway in hepatocellular carcinoma.
    Wang G; Zhou H; Gu Z; Gao Q; Shen G
    Oncol Rep; 2018 Aug; 40(2):979-987. PubMed ID: 29901157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kurarinol induces hepatocellular carcinoma cell apoptosis through suppressing cellular signal transducer and activator of transcription 3 signaling.
    Shu G; Yang J; Zhao W; Xu C; Hong Z; Mei Z; Yang X
    Toxicol Appl Pharmacol; 2014 Dec; 281(2):157-65. PubMed ID: 24997323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autocrine Human Growth Hormone Promotes Invasive and Cancer Stem Cell-Like Behavior of Hepatocellular Carcinoma Cells by STAT3 Dependent Inhibition of CLAUDIN-1 Expression.
    Chen YJ; You ML; Chong QY; Pandey V; Zhuang QS; Liu DX; Ma L; Zhu T; Lobie PE
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28617312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of chaperonin containing TCP1, subunit 3 predicts poor prognosis in hepatocellular carcinoma.
    Cui X; Hu ZP; Li Z; Gao PJ; Zhu JY
    World J Gastroenterol; 2015 Jul; 21(28):8588-604. PubMed ID: 26229401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma.
    Mano Y; Aishima S; Fujita N; Tanaka Y; Kubo Y; Motomura T; Taketomi A; Shirabe K; Maehara Y; Oda Y
    Pathobiology; 2013; 80(3):146-54. PubMed ID: 23364389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-383 inhibits cell growth and promotes cell apoptosis in hepatocellular carcinoma by targeting IL-17 via STAT3 signaling pathway.
    Wang J; Lu L; Luo Z; Li W; Lu Y; Tang Q; Pu J
    Biomed Pharmacother; 2019 Dec; 120():109551. PubMed ID: 31648164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bazedoxifene exhibits growth suppressive activity by targeting interleukin-6/glycoprotein 130/signal transducer and activator of transcription 3 signaling in hepatocellular carcinoma.
    Ma H; Yan D; Wang Y; Shi W; Liu T; Zhao C; Huo S; Duan J; Tao J; Zhai M; Luo P; Guo J; Tian L; Mageta L; Jou D; Zhang C; Li C; Lin J; Lv J; Li S; Lin L
    Cancer Sci; 2019 Mar; 110(3):950-961. PubMed ID: 30648776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
    Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J
    J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LINC00346 promotes hepatocellular carcinoma progression via activating the JAK-STAT3 signaling pathway.
    Yin YZ; Zheng WH; Zhang X; Chen YH; Tuo YH
    J Cell Biochem; 2020 Jan; 121(1):735-742. PubMed ID: 31478228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of signal transducer and activator of transcription 3 expression by RNA interference suppresses growth of human hepatocellular carcinoma in tumor-bearing nude mice.
    Li J; Piao YF; Jiang Z; Chen L; Sun HB
    World J Gastroenterol; 2009 Jun; 15(21):2602-8. PubMed ID: 19496189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.